Results 121 to 130 of about 5,781 (240)

imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management [PDF]

, 2016
The complexity of the clinical management of neuroendocrine neoplasia (NEN) is exacerbated by limitations in imaging modalities and a paucity of clinically useful biomarkers.
Ambrosini, Valentina, Baum, Richard P., Bodei, Lisa, Kidd, Mark, Krenning, Eric, Kulke, Matthew, Oberg, Kjell, Pavel, Marianne, Prasad, Vikas [u.v.m.], Sundin, Anders, Tesselaar, Margot   +10 more
core   +1 more source

Improvement of Malignant Glioma Treatment: Preclinical evaluation of adenoviral gene therapy and PRRT [PDF]

, 2007
Glioblastoma multiforme (GBM) is the most aggressive type of malignant glioma (WHO grade 4). Patients suffering from a GBM have a median survival of less than a year after diagnosis despite the recent developments in neurosurgery, radiotherapy and ...
Verwijnen, S.M. (Suzanne)
core   +1 more source

68Ga-DOTATATE PET/CT to predict response to peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumours (NETs).

Journal of Clinical Oncology, 2017
4093 Background: PRRT represents a step change in NET management, significantly improving survival. However, objective response to PRRT, approximately 20%, is poor. There are no predictive biomarkers of response. Uptake on 68Ga-DOTATATE PET/CT imaging is used to assess patient suitability for PRRT, highlighting the presence of somatostatin receptors (
Sharma, R, Wang, WM, Evans, J, Yusuf, S, AL-Nahhas, A, Mauri, F, Barwick, T, Aboagye, E   +7 more
openaire   +2 more sources

A Care Process Model to Deliver 177Lu-Dotatate Peptide Receptor Radionuclide Therapy for Patients With Neuroendocrine Tumors

Frontiers in Oncology, 2019
Purpose: To develop a care process model for the delivery of peptide receptor radionuclide therapy (PRRT) with lutetium-177 (177Lu)-Dotatate for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs ...
Pashtoon Murtaza Kasi, Catherine L. Maige, Faisal Shahjehan, Jessica M. Rodgers, Debora L. Aloszka, Ashton Ritter, Margaret L. Andrus, Jessica M. Mcmillan, Kabir Mody, Akash Sharma, Manoj K. Jain   +10 more
doaj   +1 more source

Studi Awal Estimasi Dosis Internal 177lu-dota Trastuzumab pada Manusia Berbasis Uji Biodistribusi pada Mencit [PDF]

, 2015
STUDI AWAL ESTIMASI DOSIS INTERNAL 177Lu-DOTA TRASTUZUMAB PADA MANUSIA BERBASIS UJI BIODISTRIBUSI PADA MENCIT. Radiofarmaka baru untuk pengobatan penyakit kanker payudara tipe HER-2, 177Lu-DOTA Trastuzumab, telah berhasil diproduksi oleh Pusat Teknologi ...
Aguswarini, S. (Sri), Hidayat, B. (Basuki), Hidayati, N. R. (Nur), Humani, T. S. (Titis), Karyadi, M. (mr), Masjhur, J. S. (Johan), Massora, S. (Stepanus), Mutalib, A. (Abdul), Ramli, M. (Martalena), Sastramihardja, H. (Herry), Setyowati, S. (Sri), Susilo, V. Y. (Veronika), Sutari, M. (Mrs), Triningsih, M. (mrs)   +13 more
core   +2 more sources

Imaging heterogeneity of peptide delivery and binding in solid tumors using SPECT imaging and MRI [PDF]

, 2016
Background: As model system, a solid-tumor patient-derived xenograft (PDX) model characterized by high peptide receptor expression and histological tissue homogeneity was used to study radiopeptide targeting.
Bernsen, M.R. (Monique), Bol, K. (Karin), Brunel, L. (Luc), Fehrentz, J.-A. (Jean-Alain), Haeck, J.C. (Joost), Jong, M. (Marion) de, Martinez, J. (Jean), Ridder, C.M.A. (Corrina) de, Veenland, J.F. (Jifke), Weerden, W.M. (Wytske) van   +9 more
core   +1 more source

Cutaneous Neuroendocrine Metastases of Visceral Origin Responsive to Surgical Resection and Targeted Radionuclide Therapy

Case Reports in Dermatological Medicine
Neuroendocrine neoplasms (NENs) encompass a diverse range of biologically and behaviorally distinct epithelial malignancies that derive from neuroendocrine cells. These neoplasms are able to secrete a variety of bioactive amines or peptide hormones.
Eleanor Tung-Hahn, Ghassan El-Haddad, Jonathan Strosberg   +2 more
doaj   +1 more source

P06.04 * PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) WITH 90Y-DOTATOC TARGETING OF RECURRENT ATYPICAL MENINGIOMA: A CASE REPORT [PDF]

, 2014
Sarah Iglseder, Martha Nowosielski, Armin Muigg, Günther Stockhammer, Christian F. Freyschlag, Johannes Lanbach, Meinhard Nevinny‐Stickel, Sabine Buxbaum, Christian Uprimny, Irene Virgolini   +9 more
openalex   +1 more source

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

, 2023
Çağlar Ünal
openalex   +1 more source

417P Availability and Utility of Functional Imaging (FI) and Peptide Receptor Radionuclide Therapy (PRRT) in the CommNETS Collaboration (Australia, Canada and New Zealand) [PDF]

, 2016
Bryan Chan, Hao‐Wen Sim, A. Ravikumar, Dale L. Bailey, Dominic Chan, Ben Lawrence, Alexander McEwan, Nick Pavlakis, Eva Segelov, Sheldon M. Singh, Paul Roach, David Wyld   +11 more
openalex   +3 more sources